Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio

Ultra Nasdaq Biotechnology 2X ETF (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIB
Company	Ultra Nasdaq Biotechnology 2X ETF
Price Information
Exchange	NASDAQ
Open	51.00
High	53.70
Low	51.00
Last	52.58
Change	+2.13
% Change	+4.22%
Volume	21,900
20-Day Average Volume	24,540
Previous Close	50.45
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	51.01
20-Day Raw Stochastic	65.15%
20-Day Relative Strength	49.01%
Weighted Alpha	-5.73
Today's Opinion	8% Sell
Previous Opinion	56% Sell
Last Month's Opinion	40% Buy
Performance
5-Days
%Chg	+4.91% since 04/24/24
Low	47.98 on 04/25/24
High	53.70 on 05/01/24
1-Month
%Chg	-7.51% since 04/01/24
Low	47.19 on 04/19/24
High	55.66 on 04/02/24
3-Month
%Chg	-10.18% since 02/01/24
Low	47.19 on 04/19/24
High	62.45 on 02/27/24
6-Month
%Chg	+22.82% since 11/01/23
Low	40.54 on 11/10/23
High	62.45 on 02/27/24
Key Statistics
Market Capitalization, $K	85,705
Shares Outstanding, K	1,630
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.63
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	06/27/14
Most Recent Dividend	0.040 on 03/20/24
Next Ex-Dividends Date	03/20/24
Ratios
Price/Earnings ttm	0.00